These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8512332

  • 21. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 22. Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors.
    Miyagami M, Tsubokawa T, Tazoe M, Kagawa Y.
    Neurol Med Chir (Tokyo); 1990 Aug; 30(8):582-90. PubMed ID: 1703636
    [Abstract] [Full Text] [Related]

  • 23. [Medical treatment of inoperable malignant glioma. Non-superselective intra-arterial chemotherapy with HECNU followed by conventional radiotherapy].
    Chiras J, Fauchon F, Poisson M, Debussche C, Chauveinc L, Pereon Y, Guérin RA, Bories J.
    Rev Neurol (Paris); 1989 Aug; 145(12):829-37. PubMed ID: 2482527
    [Abstract] [Full Text] [Related]

  • 24. Influence of modes of ACNU administration on tissue and blood drug concentration in malignant brain tumors.
    Hori T, Muraoka K, Saito Y, Sasahara K, Inagaki H, Inoue Y, Adachi S, Anno Y.
    J Neurosurg; 1987 Mar; 66(3):372-8. PubMed ID: 3469331
    [Abstract] [Full Text] [Related]

  • 25. [Two cases of central nervous system leukemia which responded excellently to intra-arterial injection of ACNU].
    Ohyasiki K, Ohsumi A, Ito H, Umehara S, Ohyashiki J, Yunokawa K, Osamura S, Tomita T, Ohta Y.
    Gan To Kagaku Ryoho; 1982 May; 9(5):942-7. PubMed ID: 6964042
    [Abstract] [Full Text] [Related]

  • 26. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.
    McAllister LD, Doolittle ND, Guastadisegni PE, Kraemer DF, Lacy CA, Crossen JR, Neuwelt EA.
    Neurosurgery; 2000 Jan; 46(1):51-60; discussion 60-1. PubMed ID: 10626935
    [Abstract] [Full Text] [Related]

  • 27. Advances in chemotherapy for brain tumors.
    Conrad CA, Milosavljevic VP, Yung WK.
    Neurol Clin; 1995 Nov; 13(4):795-812. PubMed ID: 8583997
    [Abstract] [Full Text] [Related]

  • 28. [Treatment of primary cerebral lymphoma. General principles and results].
    Bataille B.
    Neurochirurgie; 1997 Nov; 43(6):372-5. PubMed ID: 9706615
    [Abstract] [Full Text] [Related]

  • 29. Intra-arterial chemotherapy with ACNU for the treatment of glioblastoma. Preliminary experience.
    Roosen N, Lins E, Kiwit JC, Schirmer M, Bock WJ.
    Acta Radiol Suppl; 1986 Nov; 369():220-2. PubMed ID: 2980456
    [Abstract] [Full Text] [Related]

  • 30. Primary brain lymphomas after kidney transplantation: presentation and outcome.
    Snanoudj R, Durrbach A, Leblond V, Caillard S, Hurault De Ligny B, Noel C, Rondeau E, Moulin B, Mamzer-Bruneel MF, Lacroix C, Charpentier B.
    Transplantation; 2003 Sep 27; 76(6):930-7. PubMed ID: 14508356
    [Abstract] [Full Text] [Related]

  • 31. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V, Cocconi G, Michiara M, Di Costanzo F, Fosser V, Tonato M, Carlini P, Boni C, Di Sarra S.
    Cancer; 1999 Apr 01; 85(7):1599-605. PubMed ID: 10193952
    [Abstract] [Full Text] [Related]

  • 32. [Effectiveness of DeVIC chemotherapy for recurrent primary central nervous system lymphoma].
    Takasu S, Wakabayashi T, Kajita Y, Hatano N, Hatano H, Usui T, Kinoshita T, Yoshida J.
    No Shinkei Geka; 2000 Sep 01; 28(9):789-94. PubMed ID: 11025878
    [Abstract] [Full Text] [Related]

  • 33. Local drug delivery in recurrent malignant gliomas.
    Boiardi A, Eoli M, Salmaggi A, Lamperti E, Botturi A, Solari A, Di Meco F, Broggi G, Silvani A.
    Neurol Sci; 2005 May 01; 26 Suppl 1():S37-9. PubMed ID: 15883691
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 01; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.